VAV1 and breast neoplasm: The amount of Vav1 inside the nucleus of breast tumor cells seems to be independent also from the diversity of the different clinicopathological subtypes, identified by the criteria of Goldhirsch et al. [16] and currently of practical use for therapeutic purposes.